SFAs, such as palmitic acid (5787.41 ± 718.52 μM) and stearic acid (1906.71 ± 235.23 μM), were upregulated in psoriasis patients and decreased significantly after anti-IL-17A mAb treatment (Fig. 3b). The gene discussed is IL17A; the disease is psoriasis.